Sign Up Today and Learn More About UltraSight Stock
Invest in or calculate the value of your shares in UltraSight or other pre-IPO companies through EquityZen's platform.
UltraSight Stock
UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions.
About UltraSight Stock
Founded
2018
Industries
Software, Artificial Intelligence, Data and Analytics
UltraSight Press Mentions
Stay in the know about the latest news on UltraSight
UltraSight™ Partners with Jefferson Health to Expand Access to Cardiac Imaging Through its Echo Stewardship Platform
einpresswire • Jan 07, 2026
UltraSight™ Receives FDA Clearance to Expand Its AI-Guided Cardiac Echo Stewardship Platform Across Ultrasound Systems
einpresswire • Jan 06, 2026
Texas ACC Conference Spotlights How AI is Expanding Access to Cardiac Imaging
einpresswire • Nov 01, 2025
UltraSight™ Achieves Enrollment Milestones in Cleveland Clinic and Brigham and Women’s Clinical Studies
einpresswire • Sep 12, 2025
AI in Cardiology Market to Grow by $10.38 Billion at 46.1% CAGR to 2029: Analysis of Emerging Trends, Key Challenges, Regional Demand Drivers and the Competitive Environment
globenewswire • Aug 14, 2025
UltraSight Management
Leadership team at UltraSight
Member of Board of Directors
Chang Kim
Board of Directors
Richard Heinick
Join now and verify your accreditation status to gain access to:
- UltraSight Current Valuation
- UltraSight Stock Price
- UltraSight Management
- Available deals in UltraSight and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- UltraSight Cap Table and Funding History by Share Class and Liquidity Preferences
- UltraSight Revenue and Financials
- UltraSight Highlights
- UltraSight Business Model
- UltraSight Risk Factors
- UltraSight Research Report from SACRA Research
Trading UltraSight Stock
How to invest in UltraSight stock?
Accredited investors can buy pre-IPO stock in companies like UltraSight through EquityZen funds. These investments are made available by existing UltraSight shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell UltraSight stock?
Shareholders can sell their UltraSight stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."